The Biden administration is allowing the monkeypox vaccine to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.
"In recent weeks the monkeypox virus has continued to spread at a rate that has made it clear our current vaccine supply will not meet the current demand," said FDA Commissioner Dr. Robert M. Califf."This will increase the total number of doses available for use by up to five fold."The FDA authorization also allows those under 18 who are considered at high risk of monkeypox infection to get the shot.
Under the new dosing plan, the remaining 400,000 vials of vaccine will"have the potential to provide up to 2 million doses to Americans," said Robert Fenton, the White House monkeypox response coordinator. "There is no traditional assessment of this vaccine," said Califf, adding that the vaccine was approved based on its"immunological response, not on clinical outcomes."of monkeypox in the U.S., and that's likely an undercount given ongoing testing challenges.
Monkeypox causes lesions on the skin or mucous membranes. When the lesions rub up against another person's skin or mucous membranes, the virus can be transmitted, especially if the uninfected skin is damaged or broken. Most cases in the U.S. have been traced back to male-to-male sexual contact, according to the latest data from the Centers for Disease Control and Prevention.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two FDA-Approved Drugs Can Improve Cognition and Curb Alzheimer’sThe psychiatric medications enhance Alzheimer's patient's cognition. According to a study by researchers at the University of Colorado Anschutz Medical Campus, two widely used psychiatric drugs show indications of treating Alzheimer's disease symptoms, including enhancing cognition. “The people
Read more »
There’s a Monkeypox Treatment Drug Approved by the FDA—Here’s What We KnowThe antiviral medication is hard to get, and it protects against orthopox viruses.
Read more »
FDA expands monkeypox vaccine authorization to increase dose supply five-foldThe FDA will allow health-care providers to administer the shots through intradermal injection, or between the layers of the skin, for adults.
Read more »
FDA issues emergency use authorization for new monkeypox vaccine protocolThere is a new protocol for monkeypox vaccines. On Tuesday, the FDA issued an emergency use authorization. It allows health care providers to change how the vaccine is administered. DaveCarlinTV reports.
Read more »
FDA authorizes change in how monkeypox vaccine is givenThe US Food and Drug Administration issued an emergency use authorization Tuesday that allows health-care providers to change how the Jynneos monkeypox vaccine is administered, stretching out the supply amid high demand.
Read more »
FDA Adopts Policy to Stretch Monkeypox Vaccine SuppliesThe changes mean public-health officials could reach five times as many people with Bavarian Nordic A/S’s Jynneos vaccine.
Read more »